Ars Wealth Advisors Group, LLC Biogen Inc. Transaction History

Ars Wealth Advisors Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $210,291 - $242,997	-764 Reduced 47.45%	846 $240,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $53,877 - $61,391	-210 Reduced 11.54%	1,610 $447,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $8,330 - $10,121	33 Added 1.85%	1,820 $503,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $347,911 - $479,738	1,787 New	1,787 $477,000
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $418,778 - $577,457	-2,151 Closed	0 $477,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $82,142 - $97,682	-438 Reduced 16.92%	2,151 $439,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $64,137 - $80,810	331 Added 14.66%	2,589 $545,000
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $78,148 - $100,431	349 Added 18.28%	2,258 $542,000
Q3 2021 Oct 26, 2021	BUY	$282.99 - $369.05 $540,227 - $704,516	1,909 New	1,909 $540,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.